BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 24055690)

  • 1. Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.
    Tewes F; Ehrhardt C; Healy AM
    Eur J Pharm Biopharm; 2014 Jan; 86(1):98-104. PubMed ID: 24055690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
    Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
    Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.
    McBride AA; Price DN; Muttil P
    Methods Mol Biol; 2017; 1530():99-108. PubMed ID: 28150197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-β-cyclodextrin with amorphous raffinose or trehalose.
    Amaro MI; Tajber L; Corrigan OI; Healy AM
    Pharm Res; 2015 Jan; 32(1):180-95. PubMed ID: 25074469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of novel magnetic nano-in-microparticles for site-specific pulmonary drug delivery.
    McBride AA; Price DN; Lamoureux LR; Elmaoued AA; Vargas JM; Adolphi NL; Muttil P
    Mol Pharm; 2013 Oct; 10(10):3574-81. PubMed ID: 23964796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.
    Price DN; Stromberg LR; Kunda NK; Muttil P
    Mol Pharm; 2017 Dec; 14(12):4741-4750. PubMed ID: 29068693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
    Devrim B; Bozkır A; Canefe K
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
    Meenach SA; Anderson KW; Zach Hilt J; McGarry RC; Mansour HM
    Eur J Pharm Sci; 2013 Jul; 49(4):699-711. PubMed ID: 23707466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release microparticle dry powders of chloramphenicol palmitate or thiamphenicol palmitate prodrugs for lung delivery as aerosols.
    Nurbaeti SN; Brillault J; Tewes F; Olivier JC
    Eur J Pharm Sci; 2019 Oct; 138():105028. PubMed ID: 31377132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of different vitamin E carriers intended for pulmonary drug delivery.
    Laouini A; Andrieu V; Vecellio L; Fessi H; Charcosset C
    Int J Pharm; 2014 Aug; 471(1-2):385-90. PubMed ID: 24939617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting intracellular compartments by magnetic polymeric nanoparticles.
    Kocbek P; Kralj S; Kreft ME; Kristl J
    Eur J Pharm Sci; 2013 Sep; 50(1):130-8. PubMed ID: 23603023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.
    Gomez AI; Acosta MF; Muralidharan P; Yuan JX; Black SM; Hayes D; Mansour HM
    Pulm Pharmacol Ther; 2020 Oct; 64():101975. PubMed ID: 33137515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of magnetic aerosol droplets to the lung.
    Dames P; Gleich B; Flemmer A; Hajek K; Seidl N; Wiekhorst F; Eberbeck D; Bittmann I; Bergemann C; Weyh T; Trahms L; Rosenecker J; Rudolph C
    Nat Nanotechnol; 2007 Aug; 2(8):495-9. PubMed ID: 18654347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ciprofloxacin-loaded poly(vinyl alcohol) dry powder formulations for lung delivery.
    Silva DM; Paleco R; Traini D; Sencadas V
    Int J Pharm; 2018 Aug; 547(1-2):114-121. PubMed ID: 29803795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance.
    Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H
    Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.